Choices that fail health and wellbeing

5 May 2022 - NICE's expert group RAPID C-19, set up to ‘to ensure safe and timely patient access to treatments ...

Read more →

NICE plans to widen the net for data it uses in guidance

5 February 2020 - UK cost-effectiveness body NICE has said it intends to use a broader range of data and ...

Read more →

Broader types of data to be used in development of NICE guidance

4 February 2020 - An expanded evidence base could allow NICE to address evidence gaps and enhance reviews of the impact ...

Read more →

Additional evidence needed to assess histology-independent cancer drugs says paper co-authored by NICE staff

2 January 2020 - Paper looks at how histology-independent cancer drugs might be appraised. ...

Read more →

NICE explores extending its use of data to inform its guidance

25 June 2019 - NICE has revised its earlier press release on the use of real world data to inform ...

Read more →

Quality assurance of registries for health technology assessment

25 September 2018 - The aim of this study was to identify guidelines and assessment tools used by health technology agencies ...

Read more →

Using evidence from randomised controlled trials in economic models: what information is relevant and is there a minimum amount of sample data required to make decisions?

21 September 2018 - Evidence from randomised controlled trials is used to support regulatory approval and reimbursement decisions.  ...

Read more →

Assessing the value of innovative devices and diagnostics: the importance of clear and relevant claims of benefit

20 July 2018 - Large numbers of new medical devices and diagnostics are developed and health services need to identify which ...

Read more →

Can ad hoc analyses of clinical trials help personalise treatment decisions?

23 October 2017 - The value of ad hoc analyses of clinical trials may not be clear. Ad hoc analyses are ...

Read more →

Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples

13 September 2017 - Organisations such as the NICE require the synthesis of evidence from existing studies to inform their decisions—for ...

Read more →